Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individually Tailored Digital Secondary Prevention After Hospitalization for Atherosclerotic Cardiovascular Disease: a Randomized Proof-of-concept Study

NCT06738381 is registered in ClinicalTrials.gov with Vestre Viken Hospital Trust as lead sponsor.

NCT NCT06738381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06738381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individually Tailored Digital Secondary Prevention After Hospitalization for Atherosclerotic Cardiovascular Disease: a Randomized Proof-of-concept Study
Lead sponsor
Vestre Viken Hospital Trust
Phase
Not applicable
Overall status
Recruiting
Start date
February 3, 2025
Completion date
December 20, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atheroscleroses, cerebral, atheroscleroses, coronary, atherosclerotic ischemic disease